Luo Qixia, Wang Yuan, Fu Hao, Yu Xiao, Zheng Beiwen, Chen Yunbo, Berglund Björn, Xiao Yonghong
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Front Microbiol. 2020 Dec 18;11:592146. doi: 10.3389/fmicb.2020.592146. eCollection 2020.
To investigate the prevalence, probable mechanisms and serotype correlation of colistin resistance in clinical isolates of from patients in China, isolates were collected from fecal and blood samples of patients. In this study, 42.8% (136/318) clinical isolated were resistant to colistin. MIC distribution for colistin at serotype level among the two most prevalent serotypes originating from humans in China indicated that Enteritidis (83.9% resistance, 125/149) were significantly less susceptible than Typhimurium (15.3% resistance, 9/59, < 0.01). genes and mutations in PmrAB confer little for rate of colistin resistant isolated from human patients. Phylogenetic tree based on core-genome single nucleotide polymorphisms (SNPs) was separately by the serotypes and implied a diffused distribution of MICs in the same serotype isolates. Relatvie expression levels of colistin resistant related genes were significantly higher in non- colistin resistant Typhimurium than in colistin sensitive Typhimurium, but no discernable differences between colistin resistant and sensitive Enteritidis, indicating a different mechanism between colistin resistant Typhimurium and Enteritidis. In conclusion, colistin susceptibility and colistin resistant mechanism of clinical isolated were closely associated with specific serotypes, at least in the two most prevalent serotype Enteritidis and Typhimurium. We suggest clinical microbiology laboratory interpreting colistin MIC results in the serotype level.
为调查中国患者临床分离株中黏菌素耐药性的流行情况、可能机制及血清型相关性,从患者粪便和血液样本中收集分离株。在本研究中,42.8%(136/318)的临床分离株对黏菌素耐药。在中国源自人类的两种最常见血清型中,黏菌素在血清型水平的MIC分布表明,肠炎沙门氏菌(耐药率83.9%,125/149)比鼠伤寒沙门氏菌(耐药率15.3%,9/59,P<0.01)对黏菌素的敏感性显著更低。PmrAB基因及突变对从人类患者分离出的黏菌素耐药沙门氏菌的耐药率影响不大。基于核心基因组单核苷酸多态性(SNP)构建的系统发育树按血清型分别绘制,表明同一血清型分离株中MIC呈分散分布。黏菌素耐药相关基因的相对表达水平在非黏菌素耐药的鼠伤寒沙门氏菌中显著高于黏菌素敏感的鼠伤寒沙门氏菌,但在黏菌素耐药和敏感的肠炎沙门氏菌之间无明显差异,这表明黏菌素耐药的鼠伤寒沙门氏菌和肠炎沙门氏菌的机制不同。总之,临床分离株的黏菌素敏感性和黏菌素耐药机制与特定血清型密切相关,至少在两种最常见的血清型肠炎沙门氏菌和鼠伤寒沙门氏菌中如此。我们建议临床微生物实验室在血清型水平解释沙门氏菌黏菌素MIC结果。